Events

Prepare for the Shifting Provider Landscape: Coverage & Payment Workshop

Reg-for-AM,-workshop-for-Free

Attend this workshop for free when you register for CHI’s 2013 Annual Meeting at Genentech, Nov. 21 in South San Francisco. Learn more about CHI’s 2013 Annual Meeting.

During this workshop, you will hear from experts in the coverage and payment arena as they discuss a variety of issues facing the industry, including findings from CHI’s new coverage & payment white paper, “Driving Toward Value: Principles to Ensure Patient Access to Medical Innovation in New Payment and Delivery Models.” Click here to view the executive summary.

The Affordable Care Act is here. Are you ready for the biggest set of changes to the healthcare landscape since Medicare?

CHI has teamed up with Avalere to guide you through this time of historic changes for the biomedical industry.

The Affordable Care Act (ACA) is accelerating many changes that the healthcare sector will have to respond to in coming years. The landscape is rapidly transforming with the advent of provider consolidation, mechanisms such as Accountable Care Organizations (ACOs) and bundled payments, and broad adoption of Health Information Technology (HIT) and clinical decision support tools. The changes will impact physician autonomy and create new dynamics for how life science companies and innovators must align with the “value-driven” goals of health plans, providers, clinicians, and patients.

This workshop will focus on how your company can efficiently manage these shifting requirements and frontiers. Join Avalere Health and CHI as we identify ways to better position your organization for success in this shifting environment.

During this workshop, you will:

  • Gain insights on changes to your customers’ incentives and operating environments
  • Understand their impact on value proposition development, contracting arrangements, and investments in tools, analytics and partnerships to improve patient care
  • Learn about policy imperatives to ensure these new incentives do not penalize early adopters of new technologies and limit patient access to the best available medical care

Featured Experts:

  • Tanisha Carino, Executive Vice President, Avalere Health
  • David Gollaher, President & CEO, California Healthcare Institute
  • Stephanie Dyson, Senior Director of Government Affairs, Genentech
  • Greg Smith, U.S. Regional Head, Health Economics and Outcomes Research, P

    fizer

  • Jeff Farkas, Vice President, Health Policy and Payment, Medtronic
  • David Lansky, President & CEO, Pacific Business Group on Health
  • Jon Minken, Director Reimbursement & Managed Markets, BD Diagnostics
  • Matthew Eyles, Executive Vice President, Avalere Health
  • Ann Boynton, Deputy Executive Officer of Benefit Programs Policy and Planning, CalPERs
  • David Joyner, COO, Hill Physicians Medical Group

When:
Wednesday, November 20, 11:30AM-5:00PM PST

Location:
Parc 55
5555 Cyril Magnin St.
San Francisco, CA 94102

Register Now Button

Cost:
CHI Members: $29
Non-CHI Members: $99

Time Agenda Item
11:30 – 12:00 p.m. Registration
12:00 – 1:00 p.m. Welcoming Remarks and Lunch

  • David Gollaher, Ph.D., President and CEO, CHI
1:00 – 1:30 p.m. State of the Healthcare System

  • Matthew Eyles, Executive Vice President, Avalere Health
1:30 – 2:45 p.m. Stories from the Field: Multi-Stakeholder Panel
Panelists will share their experiences of working in this new payment and delivery environment.

  • Moderator: Tanisha Carino, Executive Vice President, Avalere Health
  • Ann Boynton, Deputy Executive Officer of Benefit Programs Policy and Planning, CalPERs
  • David Lansky, PhD, President and CEO, Pacific Busines Group on Health
  • David Joyner, COO, Hill Physicians Medical Group
2:45 – 3:15 p.m. Break
3:15 – 4:30 p.m. Stories from the Field: Industry Panel
Panelists will share their experiences of how they are responding to this new environment and what they are doing differently (e.g., product planning, customer interactions, field team strategies)

  • Moderator: David Gollaher, Ph.D., President and CEO, CHI
  • Stephanie Dyson, Senior Director, Genentech
  • Jeff Farkas, Vice President, Health Policy and Payment, Medtronic
  • Jon Minken, Director Reimbursement & Managed Markets, BD Diagnostics
  • Greg Smith, Leader, US Outcomes Research – Oncology, Pfizer

 

4:30 – 5:00 p.m. The Policy Perspective/Wrap-up

  • David Gollaher, Ph.D., President and CEO, CHI